UTAH MEDICAL PRODUCTS, INC. (UTMD) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 2.07M USD | Liabilities, Current |
| Cash and equivalents | 87.53M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 3.56M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 9.00M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $2.07M | $87.53M | (m) | $3.56M | $9.00M | (m) |
| 2026-03-31 | (m) | $3.50M | $87.41M | (m) | $3.64M | $8.72M | (m) |
| 2025-12-31 | (m) | $2.60M | $85.76M | (m) | $3.52M | $7.93M | (m) |
| 2025-09-30 | (m) | $3.01M | $84.27M | (m) | $3.73M | $8.12M | (m) |
| 2025-06-30 | (m) | $2.25M | $82.18M | (m) | $3.63M | $8.23M | (m) |
| 2025-03-31 | (m) | $4.32M | $83.33M | (m) | $3.94M | $8.65M | (m) |
| 2024-12-31 | (m) | $3.76M | $82.98M | (m) | $4.09M | $8.81M | (m) |
| 2024-09-30 | (m) | $3.44M | $88.45M | (m) | $3.72M | $9.11M | (m) |
| 2024-06-30 | (m) | $3.94M | $89.22M | (m) | $3.67M | $9.06M | (m) |
| 2024-03-31 | (m) | $5.47M | $93.81M | (m) | $3.59M | $9.24M | (m) |
| 2023-12-31 | (m) | $4.71M | $92.87M | (m) | $3.39M | $9.58M | (m) |
| 2023-09-30 | (m) | $4.18M | $88.21M | (m) | $3.49M | $9.71M | (m) |
| 2023-06-30 | (m) | $5.14M | $84.62M | (m) | $3.60M | $10.12M | (m) |
| 2023-03-31 | (m) | $6.07M | $80.91M | (m) | $3.82M | $9.94M | (m) |
| 2022-12-31 | (m) | $5.96M | $75.05M | (m) | $5.54M | $8.81M | (m) |
| 2022-09-30 | (m) | $6.27M | $69.51M | (m) | $6.03M | $8.31M | (m) |
| 2022-06-30 | (m) | $4.44M | $66.22M | (m) | $4.94M | $7.34M | (m) |
| 2022-03-31 | (m) | $6.10M | $65.87M | (m) | $5.72M | $7.37M | (m) |
| 2021-12-31 | (m) | $3.75M | $60.97M | (m) | $5.13M | $6.60M | (m) |
| 2021-09-30 | (m) | $5.01M | $64.32M | (m) | $4.85M | $6.30M | (m) |
| 2021-06-30 | (m) | $4.43M | $59.51M | (m) | $4.61M | $6.12M | (m) |
| 2021-03-31 | (m) | $4.57M | $56.03M | (m) | $4.16M | $5.97M | (m) |
| 2020-12-31 | (m) | $3.79M | $51.59M | (m) | $4.10M | $6.22M | (m) |
| 2020-09-30 | (m) | $3.63M | $46.29M | (m) | $4.28M | $6.30M | (m) |
| 2020-06-30 | (m) | $3.24M | $42.35M | (m) | $3.79M | $6.58M | (m) |
| 2020-03-31 | (m) | $3.80M | $39.61M | (m) | $4.41M | $6.76M | (m) |
| 2019-12-31 | (m) | $3.45M | $42.79M | (m) | $4.74M | $6.91M | (m) |
| 2019-09-30 | (m) | $3.69M | $37.39M | (m) | $5.07M | $6.71M | (m) |
| 2019-06-30 | (m) | $3.82M | $32.88M | (m) | $5.24M | $7.71M | (m) |
| 2019-03-31 | (m) | $7.04M | $32.66M | (m) | $4.91M | $7.65M | (m) |
| 2018-12-31 | (m) | $5.26M | $51.11M | (m) | $3.96M | $5.41M | (m) |
| 2018-09-30 | (m) | $4.77M | $49.35M | (m) | $4.48M | $4.92M | (m) |
| 2018-06-30 | (m) | $5.25M | $45.87M | (m) | $4.53M | $5.23M | (m) |
| 2018-03-31 | (m) | $5.12M | $42.85M | (m) | $4.21M | $5.56M | (m) |
| 2017-12-31 | (m) | $5.28M | $39.88M | (m) | $3.62M | $5.24M | (m) |
| 2017-09-30 | (m) | $5.18M | $37.44M | (m) | $4.73M | $5.04M | (m) |
| 2017-06-30 | (m) | $4.39M | $33.74M | (m) | $4.47M | $4.80M | (m) |
| 2017-03-31 | (m) | $5.37M | $30.68M | (m) | $4.18M | $4.76M | (m) |
| 2016-12-31 | (m) | $3.02M | $26.30M | (m) | $3.21M | $4.54M | (m) |
| 2016-09-30 | (m) | $5.53M | $31.56M | (m) | $5.03M | $4.53M | (m) |
| 2016-06-30 | (m) | $5.18M | $29.39M | (m) | $4.98M | $4.10M | (m) |
| 2016-03-31 | (m) | $6.33M | $27.52M | (m) | $5.40M | $4.49M | (m) |
| 2015-12-31 | (m) | $4.07M | $23.28M | (m) | $4.56M | $4.20M | (m) |
| 2015-09-30 | (m) | $5.74M | $21.62M | (m) | $5.49M | $4.45M | (m) |
| 2015-06-30 | (m) | $5.33M | $19.17M | (m) | $5.61M | $4.47M | (m) |
| 2015-03-31 | (m) | $5.36M | $16.10M | (m) | $5.01M | $4.85M | (m) |
| 2014-12-31 | (m) | $8.97M | $19.27M | (m) | $4.70M | $4.87M | (m) |
| 2014-09-30 | (m) | $9.16M | $18.25M | (m) | $4.65M | $4.87M | (m) |
| 2014-06-30 | (m) | $8.85M | $15.94M | (m) | $5.45M | $5.30M | (m) |
| 2014-03-31 | (m) | $8.55M | $15.04M | (m) | $5.08M | $5.29M | (m) |
| 2013-12-31 | (m) | $7.61M | $14.39M | (m) | $4.33M | $4.70M | (m) |
| 2013-09-30 | (m) | $9.23M | $13.87M | (m) | $4.96M | $4.66M | (m) |
| 2013-06-30 | (m) | $8.61M | $11.38M | (m) | $5.67M | $4.37M | (m) |
| 2013-03-31 | (m) | $9.02M | $10.87M | (m) | $5.36M | $4.41M | (m) |
| 2012-12-31 | (m) | $7.82M | $8.87M | (m) | $4.34M | $4.35M | (m) |
| 2012-09-30 | (m) | $11.41M | $9.29M | (m) | $5.04M | $4.71M | (m) |
| 2012-06-30 | (m) | $10.75M | $7.91M | (m) | $5.09M | $4.83M | (m) |
| 2012-03-31 | (m) | $11.80M | $8.16M | (m) | $6.07M | $4.83M | (m) |
| 2011-12-31 | (m) | $9.63M | $6.53M | (m) | $4.73M | $5.00M | (m) |
| 2011-09-30 | (m) | $10.49M | $7.04M | (m) | $5.03M | $4.96M | (m) |
| 2011-06-30 | (m) | $9.96M | $6.27M | (m) | $4.96M | $5.02M | (m) |
| 2011-03-31 | (m) | (m) | $7.01M | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | $1.90M | $3.82M | (m) | $3.16M | $3.10M | (m) |
| 2010-09-30 | (m) | (m) | $3.85M | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | $3.43M | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | (m) | $410.00K | (m) | (m) | (m) | (m) |
| 2008-12-31 | (m) | (m) | $97.00K | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |